These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3431487)

  • 1. Effect of Streptococcus parvulus and Peptostreptococcus magnus on cytotoxin levels of Clostridium difficile in anaerobic continuous flow culture.
    Yamamoto T; Takahashi Y; Aiba Y; Ohnishi N; Ozawa A
    Microbiol Immunol; 1987; 31(10):949-58. PubMed ID: 3431487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth inhibition of Clostridium difficile by intestinal flora of infant faeces in continuous flow culture.
    Yamamoto-Osaki T; Kamiya S; Sawamura S; Kai M; Ozawa A
    J Med Microbiol; 1994 Mar; 40(3):179-87. PubMed ID: 8114067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of clindamycin on cytotoxin production by Clostridium difficile.
    Nakamura S; Mikawa M; Tanabe N; Yamakawa K; Nishida S
    Microbiol Immunol; 1982; 26(11):985-92. PubMed ID: 7167065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ability of two Clostridium difficile strains from man and hare to produce cytotoxin in vitro and in gnotobiotic rodent intestines.
    Corthier G; Dubos F; Raibaud P
    Ann Inst Pasteur Microbiol (1985); 1986; 137B(1):113-21. PubMed ID: 3435052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of metronidazole on growth and toxin production by epidemic Clostridium difficile PCR ribotypes 001 and 027 in a human gut model.
    Freeman J; Baines SD; Saxton K; Wilcox MH
    J Antimicrob Chemother; 2007 Jul; 60(1):83-91. PubMed ID: 17483547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Clostridium difficile by faecal streptococci.
    Malamou-Ladas H; Tabaqchali S
    J Med Microbiol; 1982 Nov; 15(4):569-74. PubMed ID: 7175918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tigecycline does not induce proliferation or cytotoxin production by epidemic Clostridium difficile strains in a human gut model.
    Baines SD; Saxton K; Freeman J; Wilcox MH
    J Antimicrob Chemother; 2006 Nov; 58(5):1062-5. PubMed ID: 17030519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Morphological changes in human embryonic lung fibroblasts caused by cytotoxins of various Clostridium species].
    Schallehn G; Wolff MH
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Jan; 267(3):367-78. PubMed ID: 3376617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxin production by Clostridium sordellii strains.
    Nakamura S; Tanabe N; Yamakawa K; Nishida S
    Microbiol Immunol; 1983; 27(6):495-502. PubMed ID: 6633300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxin and enterotoxin production by Clostridium difficile.
    Gianfrilli P; Luzzi I; Pantosti A; Occhionero M; Gentile G; Panichi G
    Microbiologica; 1984 Oct; 7(4):375-9. PubMed ID: 6513801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between cytotoxin production and sporulation in Clostridium difficile.
    Kamiya S; Ogura H; Meng XQ; Nakamura S
    J Med Microbiol; 1992 Sep; 37(3):206-10. PubMed ID: 1518037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nutritional aspects of cytotoxin production by Clostridium difficile.
    Osgood DP; Wood NP; Sperry JF
    Appl Environ Microbiol; 1993 Dec; 59(12):3985-8. PubMed ID: 8285703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of Clostridium difficile and Escherichia coli with microfloras in continuous-flow cultures and gnotobiotic mice.
    Wilson KH; Freter R
    Infect Immun; 1986 Nov; 54(2):354-8. PubMed ID: 3533778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of enzyme immunoassays to detect Clostridium difficile toxin from anaerobic stool culture.
    She RC; Durrant RJ; Petti CA
    Am J Clin Pathol; 2009 Jan; 131(1):81-4. PubMed ID: 19095569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical prediction rules to optimize cytotoxin testing for Clostridium difficile in hospitalized patients with diarrhea.
    Katz DA; Lynch ME; Littenberg B
    Am J Med; 1996 May; 100(5):487-95. PubMed ID: 8644759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gas chromatographic identification of Clostridium difficile and detection of cytotoxin from a modified selective medium.
    Levett PN; Phillips KD
    J Clin Pathol; 1985 Jan; 38(1):82-5. PubMed ID: 3968212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of piperacillin/tazobactam on Clostridium difficile growth and toxin production in a human gut model.
    Baines SD; Freeman J; Wilcox MH
    J Antimicrob Chemother; 2005 Jun; 55(6):974-82. PubMed ID: 15860551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of cytotoxin production by Clostridium difficile in the intestinal tracts of gnotobiotic mice inoculated with various human intestinal bacteria.
    Corthier G; Dubos F; Raibaud P
    Appl Environ Microbiol; 1985 Jan; 49(1):250-2. PubMed ID: 3977313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial interference between Clostridium difficile and normal fecal flora.
    Rolfe RD; Helebian S; Finegold SM
    J Infect Dis; 1981 Mar; 143(3):470-5. PubMed ID: 6785366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of cytotoxin producing isolates of Clostridium difficile in faeces of neonates and children in Nigeria.
    Emeruwa AC; Oguike JU
    Microbiologica; 1990 Oct; 13(4):323-8. PubMed ID: 2087200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.